Market
Home Market Community Pricing

Welcome to TradeProwl

Sign in to access your dashboard, portfolio tracking, and real-time alerts.

EOLS

Evolus, Inc. Common StockHealthcare | Drug Manufacturers - Specialty & Generic
$7.35 -0.17 -2.26% Checking... ---
5m
---
Day Range
$7.24
$7.56
52-Week Range
$3.86
$9.31
Upcoming Earnings
--- ---

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

485.47M
Market Cap
-
Forward P/E
-
Trailing P/E
-
Price/Book
-
EPS (TTM)
-
Revenue (TTM)
-
EBITDA
-
Free CF
-
Total Debt
-
Beta
-
Gross Margin
-
Op. Margin
-
Div Rate
-
Div Yield
-
Ex-Div Date
-
Sector
-
Industry
-
Short % Float

Unusual Whale Flow

Loading anomaly scanner...

Alert